- Home
- PHAR vs ZKH Comparison
PHAR vs ZKH Comparison
Compare PHAR & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PHAR | ZKH |
|---|---|---|
| Founded | 1988 | 1998 |
| Country | Netherlands | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 486.5M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | PHAR | ZKH |
|---|---|---|
| Price | $16.39 | $3.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | 23.0K | ★ 279.0K |
| Earning Date | 11-06-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $362,274,000.00 | ★ $1,236,195,501.00 |
| Revenue This Year | $24.80 | $2.44 |
| Revenue Next Year | $6.84 | $9.14 |
| P/E Ratio | $2,916.44 | ★ N/A |
| Revenue Growth | ★ 26.78 | N/A |
| 52 Week Low | $7.50 | $2.50 |
| 52 Week High | $18.12 | $4.03 |
Technical Indicators
Market Signals| Indicator | PHAR | ZKH |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 54.42 |
| Support Level | $15.76 | $3.18 |
| Resistance Level | $18.12 | $3.49 |
| Average True Range (ATR) | 0.83 | 0.15 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 28.81 | 34.52 |
Price Performance
Historical ComparisonAbout PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About ZKH ZKH Group Limited
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.